Singapore biotech startup, Tessa Therapeutics, failed to secure investors and will liquidate soon…阅读更多(Read More) 文章导航 In 50 Words: China chipmakers seek $8b via IPOs amid US restrictions In 50 Words: MoneySmart’s reverse takeover called off; firm posts 27% revenue growth